mon MARCH 4, 2019 / 4:48 pm
Wall Street drops after weak data,
healthcare slump
DJ: 25,819.65 -206.67 NAS: 7,577.57 -17.79 S&P: 2,792.81
-10.88 3/4
(Reuters) - Wall Street’s
major indexes fell on Monday, weighed down by a weak U.S. construction spending
report and declines in healthcare shares, as an initial rally on optimism over
a U.S.-China trade deal faded. U.S.
construction spending unexpectedly fell in December as investment in both
private and public projects dropped, leading economists to expect that the
government will trim its economic growth estimate for the fourth quarter. Before turning negative, stocks had climbed
following a report that U.S. President Donald Trump and Chinese President Xi
Jinping could reach a formal trade deal at a summit around March 27.
Optimism over the world’s two largest economies reaching a trade
truce already has been a significant factor fuelling the market’s rally since
late December, along with investors’ belief that the Federal Reserve will not
be aggressive in raising interest rates. The S&P 500 remains up more than
11 percent in 2019. “There has been a
pricing in of this expectation throughout the early months of 2019, which is
partly why you have had such a bullish market,” said Alicia Levine, chief
strategist at BNY Mellon Investment Management in New York. “The market expects a trade deal with China, so there
is a little bit of sell on the news here,” added Levine, who said stocks ultimately
could still move higher on a trade deal.
The Dow Jones Industrial
Average fell 206.67 points, or 0.79 percent, to 25,819.65, the S&P 500 lost
10.88 points, or 0.39 percent, to 2,792.81 and the Nasdaq Composite dropped
17.79 points, or 0.23 percent, to 7,577.57. Levine and other market
watchers also pointed to the 2,800
level for the S&P 500 as a key technical level. The benchmark index
rose as high as 2,816.88 during the session.
“You’d have to point the finger
(for the market’s drop)
at the China trade
negotiations and the fact that we hit technical resistance again at 2,800 on the S&P
500,” said Bucky Hellwig, senior vice president at BB&T Wealth
Management in Birmingham, Alabama.
Healthcare, which has underperformed this year, was the biggest
declining major S&P 500 sector, sinking 1.3 percent. Shares of UnitedHealth Group fell 4.1
percent, weighing on the Dow, while shares of other health insurers also
fell sharply. In healthcare news,
Reuters reported that OxyContin
maker Purdue Pharma LP is exploring filing for bankruptcy to address
potentially significant liabilities from lawsuits alleging the company
contributed to the opioid crisis, sending shares of some publicly-traded
sellers of opioid pain treatments lower.
Still, indexes finished above their session lows. Materials rose
0.44 percent, the most among the S&P 500 sectors. In corporate news, AT&T shares fell 2.7 percent as the
company is restructuring its WarnerMedia business, according to a memo sent to
employees on Monday and seen by Reuters.
Declining issues outnumbered advancing ones on the NYSE by a
1.38-to-1 ratio; on Nasdaq, a 1.62-to-1 ratio favored decliners. The S&P 500 posted 40 new 52-week highs
and 2 new lows; the Nasdaq Composite recorded 83 new highs and 32 new lows.
About 7.9 billion shares
changed hands in U.S.
exchanges, above the 7.3 billion daily average over the last 20 sessions.
No comments:
Post a Comment